MedPath

Nutritional Adequacy of a FODMAP Diet in Children

Phase 1
Conditions
Functional Gastrointestinal Disorders in Children
Interventions
Other: FODMAP's diet
Registration Number
NCT02117180
Lead Sponsor
Dr Anne Payne
Brief Summary

This pilot study aims to establish whether a low FODMAP diet is safe in children with functional gastrointestinal disorders. The practicality of implementing this diet will be evaluated as well as symptom improvement and quality of life. A larger intervention trial, if deemed appropriate, will then follow to assess symptom efficacy in children.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Patients aged 10-16 years
  • Informed consent and assent obtained
  • Patients with diagnosed FGID according to Rome III criteria: i.e. category H2b (irritable bowel syndrome) and H2d (childhood functional abdominal pain)
Exclusion Criteria
  • Patients with other gastrointestinal conditions (e.g. coeliac disease, inflammatory bowel disease)
  • Patients with food allergies
  • Patients with a weight for age below -2 Standard Deviations (SD) (below 0.4th centile) on the UK WHO growth charts.
  • Patients with known micronutrient deficiencies determined by blood levels prior to study
  • Patients without informed consent and assent obtained

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
FODMAP's dietFODMAP's dietA diet low in Fermentable Oligosaccharides, Disaccharides, Monosaccharides And Polyols (FODMAPs)
Primary Outcome Measures
NameTimeMethod
Energy and nutrient intakeBaseline, 6 weeks

Energy and nutrient intake will be assessed using a 4-day estimated food diary at baseline and 6-weeks after dietary intervention. Comparison will be made between baseline and 6-week data and with United Kingdom (UK) Reference Nutrient Intakes.

Secondary Outcome Measures
NameTimeMethod
Anthropometry: weight and mid-arm circumferenceBaseline, 6 weeks

Anthropometric measurements will be taken at baseline and 6 weeks after dietary intervention. Comparison will be made between baseline and 6-week data for weight and mid upper arm circumference, as well as comparing both baseline and 6-week data to the UK-WHO growth standards.

Practicality of the FODMAP diet; impact of diet on Functional Gastro-Intestinal .Disorders (FGID) symptoms and stoolsBaseline, 6 weeks

Practicality of the FODMAP diet will be evaluated using a standardised structured questionnaire.

The impact of a low FODMAP diet on FGID symptoms and stools will be assessed using a validated symptom questionnaire and the Bristol Stool Chart.

The impact of a low FODMAP diet on quality of life will be assessed using the Pediatric Quality of Life Inventory (PedsQL) Gastrointestinal Symptoms Module.

Trial Locations

Locations (1)

Chelsea and Westminster NHS Foundation Trust

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath